Bellevue Life Sciences Acquisition (BLACW) Institutional Ownership

$0.02
0.00 (0.00%)
(As of 05/3/2024 ET)

Institutional Ownership Changes (13F Filings) for Bellevue Life Sciences Acquisition (NASDAQ:BLACW)

Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$29.55K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$16.35K
Get BLACW Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bellevue Life Sciences Acquisition stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Bellevue Life Sciences Acquisition Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2023Mangrove Partners204,072$2.09M0.1%-50.7%0.000%
5/11/2023Highbridge Capital Management LLC422,158$34K0.0%N/A0.000%
(Data available from 1/1/2016 forward)

BLACW Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BLACW shares?

During the previous two years, the following institutional investors and hedge funds held shares of Bellevue Life Sciences Acquisition shares: Mangrove Partners ($2.09M), Highbridge Capital Management LLC ($34K).Learn more on BLACW's institutional investors.

Which institutional investors have been buying Bellevue Life Sciences Acquisition stock?

The following institutional investors have purchased Bellevue Life Sciences Acquisition stock in the last 24 months: Highbridge Capital Management LLC ($422.16K).

How much institutional buying is happening at Bellevue Life Sciences Acquisition?

Institutional investors have bought a total of 422,158 shares in the last 24 months. This purchase volume represents approximately $29.55K in transactions.

Which Bellevue Life Sciences Acquisition major shareholders have been selling company stock?

The following institutional investors have sold Bellevue Life Sciences Acquisition stock in the last 24 months: Mangrove Partners ($209.68K).

How much institutional selling is happening at Bellevue Life Sciences Acquisition?

Institutional investors have sold a total of 209,678 shares in the last 24 months. This volume of shares sold represents approximately $16.35K in transactions.


This page (NASDAQ:BLACW) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners